Detalhe da pesquisa
1.
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Therap Adv Gastroenterol
; 17: 17562848231221713, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187926
2.
The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU.
Inflamm Bowel Dis
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518109
3.
Jejunal gist simulating a uterine myoma: A case report.
Int J Surg Case Rep
; 106: 108257, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37137174
4.
Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis.
Front Med (Lausanne)
; 9: 837294, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35783609
5.
Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study.
Aliment Pharmacol Ther
; 55(11): 1402-1413, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35224758
6.
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.
Front Med (Lausanne)
; 9: 823900, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178413
7.
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu.
J Clin Med
; 10(19)2021 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34640421
8.
Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry.
Aliment Pharmacol Ther
; 52(6): 1017-1030, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32770851